Transplant survival and clinical course after pretransplant HLA-A and B matched blood transfusions: a single centre study.
The effects of HLA-A and B matched pretransplant blood transfusions on the outcome of primary cadaveric kidney transplantation were studied prospectively in a group of 15 patients who had never received a transplant and had never been pregnant. From our study, prolongation of graft survival could be demonstrated for patients receiving pretransplant HLA-A and B matched blood transfusions. The clinical course was comparable to that found in a group of patients who received random pretransplant blood transfusions, although there were considerably more patients in this latter group hospitalised for a very long period, a fact which could be attributed mainly to viral infections.
D000293:Adolescent; D000328:Adult; D001788:Blood Grouping and Crossmatching; D001803:Blood Transfusion; D002102:Cadaver; D005500:Follow-Up Studies; D006084:Graft Rejection; D006085:Graft Survival; D006680:HLA Antigens / Q000276:immunology*; D015234:HLA-A Antigens; D015235:HLA-B Antigens; D006650:Histocompatibility Testing; D006801:Humans; D016030:Kidney Transplantation; D007902:Length of Stay; D008875:Middle Aged; D011446:Prospective Studies; D013997:Time Factors; D014777:Virus Diseases / Q000276:immunology
D006680:HLA Antigens; D015234:HLA-A Antigens; D015235:HLA-B Antigens